Immunogen (NASDAQ:IMGN) reported its Q1 earnings results on Friday, May 6, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Immunogen beat estimated earnings by 52.38%, reporting an EPS of $-0.1 versus an estimate of $-0.21.

Revenue was up $22.37 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $1.54 which was followed by a 7.44% increase in the share price the next day.

Here's a look at Immunogen's past performance:

To track all earnings releases for Immunogen visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.